Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „Yentreve“
Suchtreffer
Begriffe & Kennungen
Yentreve
Eintrag öffnenYentreve · 4.1 Therapeutic indications · 1
Eintrag öffnenYentreve · 4.3 Contraindications · 1
Eintrag öffnenYentreve · 4.3 · Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Eintrag öffnenYentreve · 4.3 · Liver disease resulting in hepatic impairment (see section 5.2).
Eintrag öffnenYentreve · 4.3 · Severe renal impairment (creatinine clearance <30 ml/min) (see section 4.4).
Eintrag öffnenYentreve · 4.3 · The initiation of treatment with YENTREVE is contraindicated in patients with uncontrolled hypertension that c
Eintrag öffnenYentreve · 4.3 · YENTREVE should not be used in combination with CYP1A2 inhibitors, like fluvoxamine, ciprofloxacin or enoxacin
Eintrag öffnenYentreve · 4.3 · YENTREVE should not be used in combination with nonselective, irreversible monoamine oxidase inhibitors - MAOI
Eintrag öffnenYentreve · 4.4 Special warnings and precautions for use · 1
Eintrag öffnenYentreve · 4.5 Interaction with other medicinal products and other forms of interaction · 1
Eintrag öffnenYentreve · 4.5 · 6 Serotonergic agents: In rare cases, serotonin syndrome has been reported in patients using SSRIs/SNRIs conco
Eintrag öffnenYentreve · 4.5 · Anticoagulants and antiplatelet agents: Caution should be exercised when duloxetine is combined with oral anti
Eintrag öffnenYentreve · 4.5 · CNS medicinal products: Caution is advised when YENTREVE is taken in combination with other centrally acting m
Eintrag öffnenYentreve · 4.5 · Effect of duloxetine on other medicinal products Medicinal products metabolised by CYP1A2: The pharmacokinetic
Eintrag öffnenYentreve · 4.5 · Effects of other medicinal products on duloxetine Antacids and H2 antagonists: Co-administration of YENTREVE w
Eintrag öffnenYentreve · 4.5 · Inducers of CYP1A2: Population pharmacokinetic studies analyses have shown that smokers have almost 50% lower
Eintrag öffnenYentreve · 4.5 · Inhibitors of CYP1A2: Because CYP1A2 is involved in duloxetine metabolism, concomitant use of YENTREVE with po
Eintrag öffnenYentreve · 4.5 · Medicinal products metabolised by CYP2D6: Duloxetine is a moderate inhibitor of CYP2D6. When duloxetine was ad
Eintrag öffnenYentreve · 4.5 · Monoamine oxidase inhibitors (MAOIs): Due to the risk of serotonin syndrome, duloxetine should not be used in
Eintrag öffnen